Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-023597
Filing Date
2022-06-22
Accepted
2022-06-22 18:00:11
Documents
1
Period of Report
2022-06-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4017
  Complete submission text file 0000899243-22-023597.txt   5480
Mailing Address C/O MEDIVATION, INC. 525 MARKET ST., 36TH FLOOR SAN FRANCISCO CA 94105
Business Address
Svoronos Dawn (Reporting) CIK: 0001574579 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37539 | Film No.: 221033111

Mailing Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080
Business Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Issuer) CIK: 0001629137 (see all company filings)

EIN.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations